Cochlear Limited operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cochlear Limited with three other medical equipment manufacturers in Australasia: Compumedics Limited (2020 sales of 35.07 million Australian Dollars [US$27.04 million] of which 43% was Australia and Asia Pacific), Mach7 Technologies Ltd (18.86 million Australian Dollars [US$14.54 million] of which 58% was Software licenses), and Nanosonics Limited (100.05 million Australian Dollars [US$77.14 million] of which 100% was single operating segment).

Sales Analysis. During the second fiscal quarter of 2021, sales at Cochlear Limited totalled A$743.20 million. This is a drop of 1.7% from the A$755.70 million in sales at the company during the second quarter in 2020. Cochlear Limited reported sales of A$1.32 billion (US$1.02 billion) for the fiscal year ending June of 2020. This represents a decrease of 7.4% versus 2019, when the company's sales were A$1.43 billion. Contributing to the drop in overall sales was the 7.6% decline in Emea, from A$519.20 million to A$479.60 million. There were also decreases in sales in Americas (down 5.6% to A$650.30 million) and Asia Pacific (down 6.7% to A$222.40 million) .